logo

Bio-Path Holdings Inc (BPTH)



Trade BPTH now with
  Date
  Headline
11/19/2020 7:20:49 AM Bio-Path Reports Enrollment And Dosing Of First Patient In Phase 1 Clinical Trial On BP1002
11/13/2020 7:27:32 AM Bio-Path Holdings Q3 Net Loss $3.0 Mln Or $0.80/Shr Vs Net Loss $2.2 Mln Or $0.78/Shr Last Year
8/14/2020 7:11:09 AM Bio-Path Q2 Net Loss $2.0 Mln Or $0.55/Shr Vs Loss Of $2.5 Mln Or $0.87/Shr Last Year
5/15/2020 7:11:45 AM Bio-Path Q1 Net Loss $3.3 Mln Or $0.90/shr Vs Loss Of $1.5 Mln Or $0.89/Shr Last Year
3/6/2020 7:03:15 AM Bio-Path Holdings 2019 Net Loss $8.6 Mln Or $3.24 Per Share
1/8/2020 8:21:08 AM Bio-Path Holdings Provides Update From Several Clinical Development Programs
11/21/2019 8:10:30 AM Bio-Path Says FDA Reviewed And Cleared IND Application For BP1002
8/26/2019 7:09:39 AM Bio-Path Says Patient Dosing In Amended Phase 2 Prexigebersen Trial In Acute Myeloid Leukemia
8/15/2019 7:14:07 AM Bio-Path Q2 Net Loss $2.5 Mln Or $0.87/shr Vs. Net Loss Of $1.7 Mln Or $2.96/shr Prior Year